A Food Effect Study of SPH5030 Tablets.

NCT06372223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: SPH5030
DRUG: SPH5030

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd